Corium Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Year-End Highlights
MENLO PARK, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial…